Procore (PCOR) 10-Q 5 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Oct. 29, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-40396
Entity Registrant Name	Procore Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	73-1636261
Entity Address, Address Line One	6309 Carpinteria Avenue
Entity Address, City or Town	Carpinteria
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	93013
City Area Code	866
Local Phone Number	477-6267
Title of 12(b) Security	Common stock, $0.0001 par value
Trading Symbol	PCOR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		132,018,026
Amendment Flag	false
Entity Central Index Key	0001611052
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 1,072,098	$ 379,907
Accounts receivable, net	74,472	77,692
Contract cost asset, current	15,992	13,598
Prepaid expenses and other current assets	23,882	16,772
Total current assets	1,186,444	487,969
Capitalized software development costs, net	22,543	18,538
Property and equipment, net	32,989	30,252
Right of use assets - finance leases	40,298	42,108
Right of use assets - operating leases	44,307	49,756
Contract cost asset, non-current	23,787	19,454
Intangibles, net	41,189	33,241
Goodwill	137,375	125,966
Restricted cash, non-current	3,104	3,104
Other assets	9,027	10,379
Total assets	1,541,063	820,767
Current liabilities
Accounts payable	8,913	9,012
Accrued expenses	56,063	28,492
Deferred revenue, current	240,085	213,438
Other current liabilities	12,438	10,768
Total current liabilities	317,499	261,710
Deferred revenue, non-current	4,418	6,373
Finance lease liabilities, non-current	47,704	48,835
Operating lease liabilities, non-current	41,898	46,558
Other liabilities, non-current	7,959	1,919
Total liabilities	419,478	365,395
Contingencies (Note 6)
Redeemable convertible preferred stock, $0.0001 par value, 85,734,623 and 0 shares authorized at December 31, 2020 and September 30, 2021, respectively; 85,331,278 and 0 shares issued and outstanding at December 31, 2020 and September 30, 2021, respectively.		727,474
Stockholders’ (deficit) equity
Preferred stock, $0.0001 par value, 0 and 100,000,000 shares authorized at December 31, 2020 and September 30, 2021, respectively; 0 shares issued and outstanding at December 31, 2020 and September 30, 2021.
Common stock, $0.0001 par value, 138,490,810 and 1,000,000,000 shares authorized at December 31, 2020 and September 30, 2021, respectively; 30,707,113 and 131,956,462 shares issued and outstanding at December 31, 2020 and September 30, 2021, respectively.	13	3
Additional paid-in capital	1,733,411	124,755
Accumulated other comprehensive income (loss)	(599)	187
Accumulated deficit	(611,240)	(397,047)
Total stockholders’ (deficit) equity	1,121,585	(272,102)
Total liabilities, redeemable convertible preferred stock and stockholders’ (deficit) equity	$ 1,541,063	$ 820,767

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Redeemable convertible preferred stock, par value		$ 0.0001
Redeemable convertible preferred stock, shares authorized	0	85,734,623
Redeemable convertible preferred stock, shares issued	0	85,331,278
Redeemable convertible preferred stock, shares outstanding	0	85,331,278
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	100,000,000	0
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	138,490,810
Common stock, shares issued	131,956,462	30,707,113
Common stock, shares outstanding	131,956,462	30,707,113

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement Of Income And Comprehensive Income [Abstract]
Revenue	$ 131,990	$ 101,891	$ 368,718	$ 290,781
Cost of revenue	22,693	18,063	68,545	52,589
Gross profit	109,297	83,828	300,173	238,192
Operating expenses
Sales and marketing	70,356	47,410	224,226	138,110
Research and development	53,447	34,504	176,619	89,255
General and administrative	35,051	18,320	110,805	47,770
Total operating expenses	158,854	100,234	511,650	275,135
Loss from operations	(49,557)	(16,406)	(211,477)	(36,943)
Interest expense, net	(521)	(573)	(1,659)	(1,493)
Change in fair value of Series I redeemable convertible preferred stock warrant liability		1,002		(9,603)
Other income (expense), net	(653)	248	(880)	(229)
Loss before provision for income taxes	(50,731)	(15,729)	(214,016)	(48,268)
Provision for income taxes	11	224	177	468
Net loss	(50,742)	(15,953)	(214,193)	(48,736)
Less: Recognition of beneficial conversion feature on preferred stock as a deemed dividend		(547)		(547)
Net loss attributable to common stockholders	$ (50,742)	$ (16,500)	$ (214,193)	$ (49,283)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.39)	$ (0.58)	$ (2.71)	$ (1.80)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	131,438,987	28,231,857	79,145,139	27,342,923
Total comprehensive loss
Net loss	$ (50,742)	$ (15,953)	$ (214,193)	$ (48,736)
Foreign currency translation adjustment	(562)	67	(786)	35
Comprehensive loss	$ (51,304)	$ (15,886)	$ (214,979)	$ (48,701)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' (Deficit) Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative- Effect of Accounting Change Due to Adoption	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated DeficitCumulative- Effect of Accounting Change Due to Adoption	Redeemable Convertible Preferred Stock
Beginning balance at Dec. 31, 2019	$ (253,758)	$ (56)	$ 3	$ 47,043	$ 20	$ (300,824)	$ (56)
Beginning balance, shares at Dec. 31, 2019								78,863,035
Beginning balance at Dec. 31, 2019								$ 442,897
Beginning balance, shares at Dec. 31, 2019			25,394,082
Accounting Standards Update [Extensible List]		us-gaap:AccountingStandardsUpdate201613Member					us-gaap:AccountingStandardsUpdate201613Member
Exercise of stock options	5,727			5,727
Exercise of stock options, shares			1,726,099
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs								$ 152,941
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs, shares								4,355,502
Stock-based compensation	5,300			5,300
Stock-based compensation								$ 683
Foreign currency translation adjustment	(104)				(104)
Net loss	(19,034)					(19,034)
Ending balance at Mar. 31, 2020	(261,925)		$ 3	58,070	(84)	(319,914)
Ending balance, shares at Mar. 31, 2020								83,218,537
Ending balance at Mar. 31, 2020								$ 596,521
Ending balance, shares at Mar. 31, 2020			27,120,181
Beginning balance at Dec. 31, 2019	(253,758)	$ (56)	$ 3	47,043	20	(300,824)	$ (56)
Beginning balance, shares at Dec. 31, 2019								78,863,035
Beginning balance at Dec. 31, 2019								$ 442,897
Beginning balance, shares at Dec. 31, 2019			25,394,082
Net loss	(48,736)
Ending balance at Sep. 30, 2020	(265,199)		$ 3	84,359	55	(349,616)
Ending balance, shares at Sep. 30, 2020								83,614,676
Ending balance at Sep. 30, 2020								$ 612,876
Ending balance, shares at Sep. 30, 2020			28,918,169
Beginning balance at Mar. 31, 2020	(261,925)		$ 3	58,070	(84)	(319,914)
Beginning balance, shares at Mar. 31, 2020								83,218,537
Beginning balance at Mar. 31, 2020								$ 596,521
Beginning balance, shares at Mar. 31, 2020			27,120,181
Exercise of stock options	4,497			4,497
Exercise of stock options, shares			703,096
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs								$ 4,991
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs, shares								132,046
Stock-based compensation	6,124			6,124
Stock-based compensation								$ 683
Foreign currency translation adjustment	72				72
Net loss	(13,749)					(13,749)
Ending balance at Jun. 30, 2020	(264,981)		$ 3	68,691	(12)	(333,663)
Ending balance, shares at Jun. 30, 2020								83,350,583
Ending balance at Jun. 30, 2020								$ 602,195
Ending balance, shares at Jun. 30, 2020			27,823,277
Exercise of stock options	6,325			6,325
Exercise of stock options, shares			1,092,892
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs								$ 9,990
Issuance of Series I redeemable convertible preferred stock for cash, net of issuance costs, shares								264,093
Beneficial conversion feature on Series I redeemable convertible preferred stock	547			547				$ (547)
Recognition of beneficial conversion feature as a deemed dividend	(547)			(547)				547
Vesting of RSUs, shares			2,000
Stock-based compensation	9,343			9,343
Stock-based compensation								$ 691
Foreign currency translation adjustment	67				67
Net loss	(15,953)					(15,953)
Ending balance at Sep. 30, 2020	(265,199)		$ 3	84,359	55	(349,616)
Ending balance, shares at Sep. 30, 2020								83,614,676
Ending balance at Sep. 30, 2020								$ 612,876
Ending balance, shares at Sep. 30, 2020			28,918,169
Beginning balance at Dec. 31, 2020	$ (272,102)		$ 3	124,755	187	(397,047)
Beginning balance, shares at Dec. 31, 2020	85,331,278							85,331,278
Beginning balance at Dec. 31, 2020	$ 727,474							$ 727,474
Beginning balance, shares at Dec. 31, 2020			30,707,113
Exercise of stock options	11,038			11,038
Exercise of stock options, shares			1,264,484
Stock-based compensation	9,710			9,710
Stock-based compensation								$ 676
Foreign currency translation adjustment	(24)				(24)
Net loss	(13,732)					(13,732)
Ending balance at Mar. 31, 2021	(265,110)		$ 3	145,503	163	(410,779)
Ending balance, shares at Mar. 31, 2021								85,331,278
Ending balance at Mar. 31, 2021								$ 728,150
Ending balance, shares at Mar. 31, 2021			31,971,597
Beginning balance at Dec. 31, 2020	$ (272,102)		$ 3	124,755	187	(397,047)
Beginning balance, shares at Dec. 31, 2020	85,331,278							85,331,278
Beginning balance at Dec. 31, 2020	$ 727,474							$ 727,474
Beginning balance, shares at Dec. 31, 2020			30,707,113
Exercise of stock options, shares	3,439,021
Net loss	$ (214,193)
Ending balance at Sep. 30, 2021	$ 1,121,585		$ 13	1,733,411	(599)	(611,240)
Ending balance, shares at Sep. 30, 2021	0
Ending balance, shares at Sep. 30, 2021			131,956,462
Beginning balance at Mar. 31, 2021	$ (265,110)		$ 3	145,503	163	(410,779)
Beginning balance, shares at Mar. 31, 2021								85,331,278
Beginning balance at Mar. 31, 2021								$ 728,150
Beginning balance, shares at Mar. 31, 2021			31,971,597
Exercise of stock options	17,658			17,658
Exercise of stock options, shares			1,644,603
Stock-based compensation	138,055			138,055
Stock-based compensation								225
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	728,375		$ 9	728,366				$ (728,375)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, shares			85,331,278					(85,331,278)
Issuance of common stock upon initial public offering,net of underwriting discounts and offering costs	657,618		$ 1	657,617
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs, shares			10,410,000
Issuance of common stock, net of common stock with held for tax liability, upon settlement of restricted stock units	(15)			(15)
Issuance of common stock, net of common stock withheld for tax liability, upon settlement of restricted stock units, shares			1,709,527
Foreign currency translation adjustment	(200)				(200)
Net loss	(149,719)					(149,719)
Ending balance at Jun. 30, 2021	1,126,662		$ 13	1,687,184	(37)	(560,498)
Ending balance, shares at Jun. 30, 2021			131,067,005
Exercise of stock options	5,782			5,782
Exercise of stock options, shares			529,934
Stock-based compensation	40,434			40,434
Issuance of common stock upon settlement of restricted stock units			359,523
Offering costs	11			11
Foreign currency translation adjustment	(562)				(562)
Net loss	(50,742)					(50,742)
Ending balance at Sep. 30, 2021	$ 1,121,585		$ 13	$ 1,733,411	$ (599)	$ (611,240)
Ending balance, shares at Sep. 30, 2021	0
Ending balance, shares at Sep. 30, 2021			131,956,462

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Redeemable Convertible Preferred Stock
Stock issuance costs	$ 9	$ 9	$ 60

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net loss	$ (214,193)	$ (48,736)
Adjustments to reconcile net loss to net cash provided by operating activities
Stock-based compensation	185,929	22,341
Depreciation and amortization	23,269	18,898
Change in fair value of Series I redeemable convertible preferred stock warrant liability		9,603
Abandonment of long-lived assets	554	2,851
Noncash lease expense	5,600	4,807
Unrealized foreign currency (gain) loss, net	875	(338)
Deferred income taxes	93	(28)
Changes in operating assets and liabilities, net of effect of business combinations
Accounts receivable	3,383	3,363
Deferred contract cost assets	(7,073)	592
Prepaid expenses and other assets	(7,755)	(1,553)
Accounts payable	(128)	(2,451)
Accrued expenses and other liabilities	28,684	1,101
Deferred revenue	24,721	3,337
Operating lease liabilities	(3,654)	(3,715)
Net cash flow provided by operating activities	40,305	10,072
Investing activities
Purchases of property and equipment	(8,405)	(6,718)
Capitalized software development costs	(10,175)	(9,403)
Strategic investments	(3,450)
Acquisition of businesses, net of cash acquired	(19,990)	(3,325)
Net cash flow used in investing activities	(42,020)	(19,446)
Financing activities
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs		167,931
Proceeds from initial public offering, net of underwriting commissions and discounts	665,129
Proceeds from stock option exercises	35,313	15,660
Payment of debt issuance costs		(93)
Payments of deferred offering costs	(3,846)	(2,280)
Payment of deferred business acquisition consideration	(475)
Principal payments under finance lease agreements, net of proceeds from lease incentives	(1,175)	(1,050)
Net cash flow provided by financing activities	694,946	192,091
Net increase in cash, cash equivalents and restricted cash	693,231	182,717
Effect of exchange rate changes on cash	(1,040)	387
Cash, cash equivalents and restricted cash, beginning of period	383,253	121,828
Cash, cash equivalents and restricted cash, end of period	1,075,444	304,932
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	1,072,098	301,586
Restricted cash, current at end of period included in prepaid expenses and other current assets	242
Restricted cash, non-current at end of period	3,104	3,346
Cash, cash equivalents and restricted cash, end of period	1,075,444	304,932
Supplemental disclosure of cash flow information
Cash paid for interest other than finance leases	147	112
Cash (received) paid for income taxes, net	309	(23)
Cash received for lease incentives	1,381	1,012
Operating cash flows from finance leases	1,563	1,604
Operating cash flows from operating leases	5,972	5,722
Financing cash flows from finance leases	1,268	1,147
Noncash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses at period end	1,182	534
Capitalized software development costs included in accounts payable and accrued expenses at period end	1,008	94
Deferred offering costs included in accounts payable and accrued expenses at period end	310	1,624
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	728,375
Indemnity holdback consideration associated with a business combination	4,050
Stock-based compensation capitalized for software development	3,171	483
Right of use assets obtained in exchange for operating lease liabilities	$ 150	12,442
Noncash net change due to operating lease remeasurements		(1,594)
Series I Warrant
Financing activities
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs		$ 11,923

Organization And Description of

Organization And Description of Business	9 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization And Description of Business	1. Description of Business Procore Technologies, The Initial Public Offering The Company’s registration statement on Form S-1 related to its initial public offering (“IPO”) was declared effective on May 19, 2021, and the Company’s common stock began trading on the New York Stock Exchange on May 20, 2021. On May 24, 2021, the Company completed its IPO, in which it issued and sold 10,410,000 shares of common stock at a price of $67.00 per share, including 940,000 shares of common stock pursuant to the exercise in full of the underwriters’ option to purchase additional shares. The Company received $665.1 million in net proceeds, after deducting underwriting discounts and commissions of $32.3 million and before other offering costs of $7.5 million. At the closing of the IPO, all outstanding shares of redeemable convertible preferred stock were automatically converted into an aggregate of 85,331,278 shares of common stock on a one-for-one basis, further discussed in Note 8 and 9 to these condensed consolidated financial statements. Upon the effectiveness date of the registration statement for the IPO, the performance vesting condition of restricted stock units (“RSUs”) was met and the Company recognized $115.3 million of stock-based compensation expense in its condensed consolidated statement of operations, for the portion of the service period completed by employees and non-employees from the grant date through the effectiveness date of the registration statement for the IPO, as further described in Note 10 to these condensed consolidated financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2 . SUMMARY Basis The accompanying condensed consolidated financial statements include the interim financial statements of Procore Technologies, Inc. and its subsidiaries, and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are unaudited. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2020. The condensed consolidated balance sheet information as of December 31, 2020 has been derived from our audited consolidated financial statements. The condensed consolidated financial statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and include, in the opinion of management, all adjustments, consisting of normal recurring items, necessary for the fair statement of the condensed consolidated financial statements. All intercompany balances and transactions have been eliminated in consolidation. The accounting policies used in the preparation of these condensed consolidated financial statements are the same as those disclosed in the audited consolidated financial statements and related notes for the year ended December 31, 2020. Use The , , In light of the currently unknown duration and severity of the COVID-19 pandemic, we face a As of the date these condensed consolidated financial statements were issued, we are not aware of any specific event or circumstance that would require us to update our estimates or judgments or to revise the carrying value of our assets or liabilities. Judgments and assumptions may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could result in a meaningful impact on our condensed consolidated financial statements in future reporting periods. Segments We operate as a single Deferred Offering Deferred offering costs of $5.0 million Upon the closing of the IPO, Strategic Investments We hold investments in equity securities of certain privately held companies, which do not have readily determinable fair values. We have elected to measure these non-marketable investments at cost, with remeasurements to fair value only upon the occurrence of observable price changes in orderly transactions for the identical or similar securities of the same issuer, or in the event of any impairment. This election is reassessed each reporting period to determine whether a non-marketable equity security has a readily determinable fair value, in which case they would no longer be eligible for this election. All gains and losses on such equity securities, realized and unrealized, are recorded in other income (expense), net on the condensed consolidated statements of operations. We evaluate our non-marketable equity securities for impairment at each reporting period based on a qualitative assessment that considers various potential impairment indicators. If an impairment exists, a loss is recognized in the condensed consolidated statements of operations for the amount by which the carrying value exceeds the fair value of the investment. As of September 30, 2021 September 30, 2021 Fair value measurements Fair value Level 1 Level 2 Level 3 As of December 31, 2020 and September 30, 2021, the carrying value of the Company’s financial instruments included in current assets and current liabilities (including restricted cash, accounts receivable, accounts payable and accrued expenses) approximate fair value due to the short- term nature of such items. The Company classifies its money market funds recorded in cash equivalents within Level 1 of the hierarchy as the values are derived from quoted prices in active markets. As of December 31, 2020 and September 30, 2021 , cash equivalents of $ 363.1 million and $ million, respectively, were held in money market funds. In March 2020, the Company The Company's investments in equity securities of privately held companies are recorded at fair value on a non-recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company classifies these assets as Level 3 within the fair value hierarchy. For investments without a readily determinable fair value, the Company looks to observable transactions, such as the issuance of new equity by an investee, as indicators of investee enterprise value and are used to estimate the fair value of the investments. Deferred revenue Contract liabilities Remaining Performance The Recently issued accounting pronouncements — Simplifying the Accounting for Convertible Instruments In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Accounting for Contract Assets and Contract Liabilities from Customer Contracts Acquired in a Business Combination In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2021
Business Combinations [Abstract]
Business Combination	3. BUSINESS COMBINATION Indus.ai Inc. On May 3, 2021, the Company completed the acquisition of Indus.ai Inc. (“Indus”), a Canada based privately held company that offers an artificial intelligence-powered analytics platform to provide actionable insights for the construction industry, by acquiring 100% of the outstanding voting interests in Indus for preliminary purchase consideration of approximately $24.3 million in cash. Of the total purchase consideration, $4.1 million was held back to secure certain indemnification obligations (“Holdback Consideration”) in accordance with the stock purchase agreement and will be paid, subject to any indemnification claims, in 2022 on the 18-month anniversary of the acquisition. The Holdback Consideration is recorded in other liabilities on the condensed consolidated balance sheet as of September 30, 2021. The purpose of this acquisition is to accelerate the development of the Company’s artificial intelligence and machine learning solutions. The purchase consideration was primarily allocated to developed technology intangible assets with an estimated fair value of $14.8 million at the acquisition date, which was valued using the cost to rebuild method. The fair value of the remaining acquired tangible and intangible net assets was immaterial. We also recorded deferred tax liability of $2.0 million as a result of the acquisition. The Company recorded goodwill, which represents the excess of the purchase consideration over the tangible and intangible assets acquired and liabilities assumed, of $11.5 million relating to the acquisition. Goodwill is not deductible for income tax purposes. The goodwill balance is primarily attributed to the synergies expected and the skilled workforce acquired. The measurement periods for the valuation of assets acquired and liabilities assumed end as soon as information on the facts and circumstances that existed as of the acquisition date becomes available, but do not exceed 12 months. Developed technology acquired is amortized on a straight-line basis, which approximates the pattern in which the economic benefits of the technology is expected to be consumed, over its estimated useful life of five years. The amortization expense is recorded in research and development in the condensed consolidated financial statements of operations and comprehensive loss, as the acquired developed technology will be used to improve our internal research and development capabilities. The Company has not separately presented pro forma results reflecting the acquisition of Indus, or revenue and operating losses of Indus for the period from the acquisition date through September 30, 2021

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	4. INTANGIBLE ASSETS AND GOODWILL Intangible assets Our December 31, 2020 Gross Carrying Accumulated Net Carrying Amount Amortization Amount Developed technology $ 25,141 $ (5,817 ) $ 19,324 Customer relationships 16,450 (2,533 ) 13,917 Total $ 41,591 $ (8,350 ) $ 33,241 September 30, 2021 Gross Carrying Accumulated Net Carrying Amount Amortization Amount Developed technology $ 39,438 $ (10,816 ) $ 28,622 Customer relationships 16,450 (3,883 ) 12,567 Total $ 55,888 $ (14,699 ) $ 41,189 We estimate that there is no significant Three Months Ended September 30, Nine Months Ended September 30, 2020 2021 2020 2021 Cost of revenue $ 761 $ 1,086 $ 2,283 $ 3,258 Sales and marketing 404 404 1,212 1,349 Research and development 183 907 488 1,770 Total amortization of acquired intangible assets $ 1,348 $ 2,397 $ 3,983 $ 6,377 Goodwill The Beginning balance $ 125,966 Additions 11,464 Other adjustments, net (1) (55 ) Ending balance $ 137,375 (1) Includes post-closing working capital adjustments and the effect of foreign currency translation. The .

Accrued Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2021
Accrued Liabilities Current [Abstract]
Accrued Expenses	5. ACCRUED The December 31, September 30, 2020 2021 Accrued commissions and bonuses $ 14,120 $ 21,064 Accrued salary and payroll tax liabilities 5,818 13,031 Other accrued expenses 8,554 21,968 Total accrued expenses $ 28,492 $ 56,063

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Contingencies	6. CONTINGENCIES Litigation From time to time, Indemnifications In the ordinary course of business, The

Credit Facility

Credit Facility	9 Months Ended
	Sep. 30, 2021
Line Of Credit Facility [Abstract]
Credit Facility	7. CREDIT FACILITY The Company has a credit agreement (the “Credit Facility”) provided by Silicon Valley Bank, to be used for general corporate purposes, including the financing of working capital requirements. As of December 30, 2020 and September 30, 2021, the aggregate principal amount available under the Credit Facility was up to $75.0 million with the option to increase the availability up to $100.0 million. The As of each As of December 31, 2020

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock	9 Months Ended
	Sep. 30, 2021
Redeemable Convertible Preferred Stock [Abstract]
Redeemable Convertible Preferred Stock	8. REDEEMABLE CONVERTIBLE PREFERRED STOCK Upon the closing of the IPO, all of the outstanding redeemable convertible preferred stock were automatically converted into an aggregate of 85,331,278 shares of our common stock on a one-for-one basis, and the carrying value, totaling $728.4 million, was reclassified into common stock and additional paid-in capital on the condensed consolidated balance sheet. Series I redeemable In March 2020, the Company At the issuance The March 31, June 30, September 30, 2020 2020 2020 Fair value of Series I redeemable convertible preferred stock per share $ 35.04 $ 47.67 $ 49.95 Expected term (in years) 1.00 0.75 0.50 Expected volatility 66.90 % 67.80 % 59.10 % Risk-free interest rate 0.16 % 0.16 % 0.10 % Dividend yield 0.00 % 0.00 % 0.00 % The following table provides a summary of the changes in the fair value of the Company’s Series I warrant liability (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2021 2020 2021 Beginning balance $ 22,528 $ - $ - $ - Issuance of Series I warrant - - 11,923 - Change in fair value measurement of Series I warrant liability (1,002 ) - 9,603 - Ending balance $ 21,526 $ - $ 21,526 $ -

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Common Stock	9. COMMON STOCK Upon the closing of the IPO, the Company filed an Amended and Restated Certificate of Incorporation which authorized 1,000,000,000 shares of common stock with a par value of $0.0001 per share, and 100,000,000 shares of undesignated preferred stock with a par value of $0.0001 per share. Each share of common stock is entitled to one vote per share.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-based Compensation	10. STOCK-BASED 2021 Equity Incentive Plan In May 2021, the Company’s board of directors adopted, and the stockholders approved, the 2021 Equity Incentive Plan (the "2021 Plan") with the purpose of granting stock-based awards, including stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards and other forms of awards, to employees, directors, and consultants, including employees and consultants of our affiliates. A total of 30,962,615 shares of common stock are available for issuance under the 2021 Plan. Stock options The Weighted Number of Average Shares Exercise Price Outstanding at December 31, 2020 12,410,041 $ 12.51 Exercised (3,439,021 ) 10.03 Cancelled/Forfeited (599,573 ) 19.71 Outstanding at September 30, 2021 8,371,447 13.02 Exercisable at September 30, 2021 6,201,192 $ 10.81 Restricted stock units Beginning in 2018, the Company began issuing RSUs to certain employees, officers, non-employee consultants and directors. The RSUs granted prior to the IPO vest upon the satisfaction of both a service and a performance condition, if both conditions are met before the award’s expiration date. For certain awards the performance condition was satisfied solely on the effective date of a registration statement for our IPO and for other awards the performance condition was satisfied on the earlier of either the effective date of a registration statement for our IPO or a change in control. RSUs granted with service vesting conditions are generally satisfied over four years on either a quarterly or annual vesting schedule. Upon the effective date of the registration statement for the IPO, the performance vesting condition for all RSUs granted was satisfied and the A Weighted Average Number of Grant Date Shares Fair Value Outstanding at December 31, 2020 5,357,120 $ 31.20 Granted 3,016,957 69.49 Released (2,069,549 ) 31.15 Cancelled/Forfeited (610,710 ) 42.26 Outstanding at September 30, 2021 5,693,818 $ 50.32 Total unrecognized stock ‑ September 30, 2021 ‑ Restricted stock awards In July Sales of common stock During Employee Stock Purchase Plan In May 2021, the Company’s board of directors adopted, and the stockholders approved, the 2021 Employee Stock Purchase Plan (the “ESPP”), which became effective immediately prior to the effective date of the Company's IPO date. A total of 2,600,000 shares of common stock were initially reserved for issuance under the ESPP. The number of shares of our common stock reserved for issuance under the ESPP will automatically increase on January 1 of each year for a period of ten years, beginning on January 1, 2022 and continuing through January 1, 2031, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding year; and (ii) 3,900,000 shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii). The ESPP provides for consecutive offering periods that will typically have a duration of 12 months in length and is comprised of two purchase periods of six months in length. The offering periods are scheduled to start on May 16 and November 16 of each year. The first offering period commenced on the Company’s first day of trading on May 20, 2021 and is comprised of three purchase periods of approximately six months in length, scheduled to end on November 15, 2022. The ESPP provides eligible employees with an opportunity to purchase shares of the Company’s common stock through payroll deductions of up to 15% of their eligible compensation, subject to a maximum of $25,000 per calendar year. A participant may purchase a maximum of 2,500 shares of common stock during a purchase period. Amounts deducted and accumulated by the participant are used to purchase shares of common stock at the end of each six-month purchase period. The purchase price of the shares shall be 85% of the lower of the fair market value of the common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the related offering period. However, in the event the fair value of the common stock on the purchase date is lower than the fair value on the first trading day of the offering period, the offering period is terminated immediately following the purchase and a new offering period begins the following day. Participants may end their participation at any time during an offering period and will be repaid their accrued contributions that have not yet been used to purchase shares of common stock. Participation ends automatically upon termination of employment. We estimate the fair value of the ESPP purchase rights on the date of grant using the Black-Scholes option pricing model with the following assumptions during the nine months ended September 30, 2021. Risk-free interest rate 0.03% to 0.05% Expected term (in years) 0.5 to 1.5 Estimated dividend yield 0.00% Estimated weighted-average volatility 63.42% to 69.39% The term for the ESPP purchase rights is the offering period. We estimate volatility using historical volatilities of a group of public companies in a similar industry and stage of life cycle, selected by management, for a period commensurate with the term. The interest rate is derived from government bonds with a similar term to the ESPP purchase right granted. We have not declared, nor do we expect to declare dividends in the foreseeable future. Consequently, an expected dividend yield of zero was utilized. Employee payroll contributions accrued in connection with the ESPP were $7.7 million as of September 30, 2021 September 30, 2021 As of September 30, 2021 Stock-based compensation The Company recorded total stock-based compensation cost from RSUs, stock options, RSAs, ESPP and sales of stock by employees in excess of fair value as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Cost of revenue $ 633 $ 679 $ 1,168 $ 6,758 Sales and marketing 3,410 11,178 8,644 57,285 Research and development 2,898 15,064 6,747 69,627 General and administrative 3,074 11,262 5,782 52,259 Total stock-based compensation expense $ 10,015 $ 38,183 $ 22,341 $ 185,929 Stock-based compensation capitalized for software development 19 2,251 483 3,171 Total stock-based compensation cost $ 10,034 $ 40,434 $ 22,824 $ 189,100

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	11. INCOME TAXES For the three months ended September 30, 2020 and 2021, the Company recorded an income tax expense of $0.2 million and In determining In March 2021, the President

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	12. NET LOSS PER SHARE Basic Net losses Diluted accordingly, basic net loss per share attributable to common stockholders equals diluted net loss per share attributable to common stockholders. The Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Shares of common stock issuable upon conversion of redeemable convertible preferred stock 83,393,642 — 81,921,552 44,697,336 Shares of common stock issuable upon conversion of Series I warrant 1,452,513 — 980,711 — Restricted stock units subject to future vesting 4,578,156 5,834,027 3,454,658 6,057,965 Shares issuable pursuant to the ESPP — 598,844 — 261,035 Shares of common stock issuable from stock options 15,284,295 8,818,741 16,432,286 10,132,359 Total 104,708,606 15,251,612 102,789,207 61,148,695

Geographic Information

Geographic Information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Geographic Information	13. The Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Revenue by geographic region: United States $ 89,378 $ 111,774 $ 255,860 $ 315,711 Rest of the world 12,513 20,216 34,921 53,007 Total revenue $ 101,891 $ 131,990 $ 290,781 $ 368,718 Percentage of revenue by geographic region: United States 88 % 85 % 88 % 86 % Rest of the world 12 % 15 % 12 % 14 %

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2021
Restructuring And Related Activities [Abstract]
Restructuring	14. RESTRUCTURING In July 2020 We incurred $4.4 million in restructuring-related expenses in the three and nine months ended September 30, 2020. The following table summarizes the above restructuring-related expenses by line item within the condensed consolidated statements of operations and comprehensive loss (in thousands): Nine Months Ended September 30, 2020 Cost of revenue $ 127 Sales and marketing 1,763 Research and development 1,681 General and administrative 801 Total $ 4,372

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	1 5 . SUBSEQUENT EVENTS Through November 5, 2021, the Company granted an aggregate of 882,892 RSUs in connection with the acquisitions described below, at grant date fair values ranging from $90.84 to $100.10 per share, for a total grant date fair value of $81.4 million. On October 21, 2021, the Company completed the acquisition of all outstanding equity of LaborChart, Inc. (“LaborChart”), a labor management solution that facilitates labor scheduling, forecasting, office-to-field communications, certification tracking, data management, and labor analysis. The estimated purchase price is approximately $85 million in cash, subject to customary adjustments for working capital, transaction expenses, cash, indebtedness, and the determination of any consideration for post-combination services. Due to the timing of this acquisition, the initial accounting for the acquisition, including the final purchase price and purchase price allocation, which will require a valuation as of the acquisition date, is incomplete. As such, the Company is not able to disclose certain information relating to the acquisition, including the preliminary fair value of assets acquired and liabilities assumed. On November 2, 2021, the Company completed the acquisition of all outstanding equity of Express Lien, Inc. (d/b/a Levelset) (“Levelset”), a lien rights management solution. Pursuant to the merger agreement, the estimated purchase price is approximately $500 million, which consists of approximately $425 million in cash, subject to customary adjustments for working capital, transaction expenses, cash, indebtedness, and the determination of any consideration for post-combination services, and $75 million in shares of Procore common stock. 810,169 shares were issued in connection with the acquisition, determined by dividing $75 million by the volume-weighted average trading price of a share of Procore common stock as measured over thirty consecutive trading days on the New York Stock Exchange immediately prior to the closing date of the transaction. The fair value of the shares of common stock issued was $77.0 million based on the closing stock price on the date of closing of the acquisition. Of the total cash consideration, $35 million is held in escrow to secure indemnification obligations of Levelset’s former interest holders. Due to the timing of this acquisition, the initial accounting for the acquisition, including the final purchase price and purchase price allocation, which will require a valuation as of the acquisition date, is incomplete. As such, the Company is not able to disclose certain information relating to the business combination, including the preliminary fair value of assets acquired and liabilities assumed.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of presentation	Basis The accompanying condensed consolidated financial statements include the interim financial statements of Procore Technologies, Inc. and its subsidiaries, and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are unaudited. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2020. The condensed consolidated balance sheet information as of December 31, 2020 has been derived from our audited consolidated financial statements. The condensed consolidated financial statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and include, in the opinion of management, all adjustments, consisting of normal recurring items, necessary for the fair statement of the condensed consolidated financial statements. All intercompany balances and transactions have been eliminated in consolidation. The accounting policies used in the preparation of these condensed consolidated financial statements are the same as those disclosed in the audited consolidated financial statements and related notes for the year ended December 31, 2020.
Use of estimates	Use The , , In light of the currently unknown duration and severity of the COVID-19 pandemic, we face a As of the date these condensed consolidated financial statements were issued, we are not aware of any specific event or circumstance that would require us to update our estimates or judgments or to revise the carrying value of our assets or liabilities. Judgments and assumptions may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could result in a meaningful impact on our condensed consolidated financial statements in future reporting periods.
Segments	Segments We operate as a single
Deferred Offering Costs	Deferred Offering Deferred offering costs of $5.0 million Upon the closing of the IPO,
Strategic Investments	Strategic Investments We hold investments in equity securities of certain privately held companies, which do not have readily determinable fair values. We have elected to measure these non-marketable investments at cost, with remeasurements to fair value only upon the occurrence of observable price changes in orderly transactions for the identical or similar securities of the same issuer, or in the event of any impairment. This election is reassessed each reporting period to determine whether a non-marketable equity security has a readily determinable fair value, in which case they would no longer be eligible for this election. All gains and losses on such equity securities, realized and unrealized, are recorded in other income (expense), net on the condensed consolidated statements of operations. We evaluate our non-marketable equity securities for impairment at each reporting period based on a qualitative assessment that considers various potential impairment indicators. If an impairment exists, a loss is recognized in the condensed consolidated statements of operations for the amount by which the carrying value exceeds the fair value of the investment. As of September 30, 2021 September 30, 2021
Fair value measurements	Fair value measurements Fair value Level 1 Level 2 Level 3 As of December 31, 2020 and September 30, 2021, the carrying value of the Company’s financial instruments included in current assets and current liabilities (including restricted cash, accounts receivable, accounts payable and accrued expenses) approximate fair value due to the short- term nature of such items. The Company classifies its money market funds recorded in cash equivalents within Level 1 of the hierarchy as the values are derived from quoted prices in active markets. As of December 31, 2020 and September 30, 2021 , cash equivalents of $ 363.1 million and $ million, respectively, were held in money market funds. In March 2020, the Company The Company's investments in equity securities of privately held companies are recorded at fair value on a non-recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company classifies these assets as Level 3 within the fair value hierarchy. For investments without a readily determinable fair value, the Company looks to observable transactions, such as the issuance of new equity by an investee, as indicators of investee enterprise value and are used to estimate the fair value of the investments.
Deferred revenue	Deferred revenue Contract liabilities
Remaining Performance Obligation	Remaining Performance The
Recently issued accounting pronouncements—Not yet adopted	Recently issued accounting pronouncements — Simplifying the Accounting for Convertible Instruments In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Accounting for Contract Assets and Contract Liabilities from Customer Contracts Acquired in a Business Combination In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Finite-lived Intangible Assets	Our December 31, 2020 Gross Carrying Accumulated Net Carrying Amount Amortization Amount Developed technology $ 25,141 $ (5,817 ) $ 19,324 Customer relationships 16,450 (2,533 ) 13,917 Total $ 41,591 $ (8,350 ) $ 33,241 September 30, 2021 Gross Carrying Accumulated Net Carrying Amount Amortization Amount Developed technology $ 39,438 $ (10,816 ) $ 28,622 Customer relationships 16,450 (3,883 ) 12,567 Total $ 55,888 $ (14,699 ) $ 41,189
Summary of Intangible Assets Amortization Expense	Intangible assets amortization expense Three Months Ended September 30, Nine Months Ended September 30, 2020 2021 2020 2021 Cost of revenue $ 761 $ 1,086 $ 2,283 $ 3,258 Sales and marketing 404 404 1,212 1,349 Research and development 183 907 488 1,770 Total amortization of acquired intangible assets $ 1,348 $ 2,397 $ 3,983 $ 6,377
Summary of Changes in Carrying Amount of Goodwill	The Beginning balance $ 125,966 Additions 11,464 Other adjustments, net (1) (55 ) Ending balance $ 137,375 (1) Includes post-closing working capital adjustments and the effect of foreign currency translation.

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2021
Accrued Liabilities Current [Abstract]
Schedule of Components of Accrued Expenses	The December 31, September 30, 2020 2021 Accrued commissions and bonuses $ 14,120 $ 21,064 Accrued salary and payroll tax liabilities 5,818 13,031 Other accrued expenses 8,554 21,968 Total accrued expenses $ 28,492 $ 56,063

Redeemable Convertible Prefer_2

Redeemable Convertible Preferred Stock (Tables)	9 Months Ended
	Sep. 30, 2021
Redeemable Convertible Preferred Stock [Abstract]
Summary of Inputs Used in Black-Scholes Option Pricing Model in Determining Fair Value of Warrant Liability	The March 31, June 30, September 30, 2020 2020 2020 Fair value of Series I redeemable convertible preferred stock per share $ 35.04 $ 47.67 $ 49.95 Expected term (in years) 1.00 0.75 0.50 Expected volatility 66.90 % 67.80 % 59.10 % Risk-free interest rate 0.16 % 0.16 % 0.10 % Dividend yield 0.00 % 0.00 % 0.00 %
Summary of Changes in Fair Value of Warrant Liability	The following table provides a summary of the changes in the fair value of the Company’s Series I warrant liability (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2021 2020 2021 Beginning balance $ 22,528 $ - $ - $ - Issuance of Series I warrant - - 11,923 - Change in fair value measurement of Series I warrant liability (1,002 ) - 9,603 - Ending balance $ 21,526 $ - $ 21,526 $ -

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Stock Option Activity	The Weighted Number of Average Shares Exercise Price Outstanding at December 31, 2020 12,410,041 $ 12.51 Exercised (3,439,021 ) 10.03 Cancelled/Forfeited (599,573 ) 19.71 Outstanding at September 30, 2021 8,371,447 13.02 Exercisable at September 30, 2021 6,201,192 $ 10.81
Summary of Activity in Connection with RSUs	A Weighted Average Number of Grant Date Shares Fair Value Outstanding at December 31, 2020 5,357,120 $ 31.20 Granted 3,016,957 69.49 Released (2,069,549 ) 31.15 Cancelled/Forfeited (610,710 ) 42.26 Outstanding at September 30, 2021 5,693,818 $ 50.32
Schedule of Estimate Fair Value of ESPP Purchase Rights on Date of Grant	We estimate the fair value of the ESPP purchase rights on the date of grant using the Black-Scholes option pricing model with the following assumptions during the nine months ended September 30, 2021. Risk-free interest rate 0.03% to 0.05% Expected term (in years) 0.5 to 1.5 Estimated dividend yield 0.00% Estimated weighted-average volatility 63.42% to 69.39%
Summary of Total Stock-based Compensation Cost from RSUs, Stock Options, RSAs, ESPP and Sales of Stock	The Company recorded total stock-based compensation cost from RSUs, stock options, RSAs, ESPP and sales of stock by employees in excess of fair value as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Cost of revenue $ 633 $ 679 $ 1,168 $ 6,758 Sales and marketing 3,410 11,178 8,644 57,285 Research and development 2,898 15,064 6,747 69,627 General and administrative 3,074 11,262 5,782 52,259 Total stock-based compensation expense $ 10,015 $ 38,183 $ 22,341 $ 185,929 Stock-based compensation capitalized for software development 19 2,251 483 3,171 Total stock-based compensation cost $ 10,034 $ 40,434 $ 22,824 $ 189,100

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Summary of Weighted Average Potentially Dilutive Shares are Excluded from Calculation of Diluted Earnings Per Share	The Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Shares of common stock issuable upon conversion of redeemable convertible preferred stock 83,393,642 — 81,921,552 44,697,336 Shares of common stock issuable upon conversion of Series I warrant 1,452,513 — 980,711 — Restricted stock units subject to future vesting 4,578,156 5,834,027 3,454,658 6,057,965 Shares issuable pursuant to the ESPP — 598,844 — 261,035 Shares of common stock issuable from stock options 15,284,295 8,818,741 16,432,286 10,132,359 Total 104,708,606 15,251,612 102,789,207 61,148,695

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Summary of Revenue by Geographic Region	The Three Months Ended Nine Months Ended September 30, September 30, 2020 2021 2020 2021 Revenue by geographic region: United States $ 89,378 $ 111,774 $ 255,860 $ 315,711 Rest of the world 12,513 20,216 34,921 53,007 Total revenue $ 101,891 $ 131,990 $ 290,781 $ 368,718 Percentage of revenue by geographic region: United States 88 % 85 % 88 % 86 % Rest of the world 12 % 15 % 12 % 14 %

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2021
Restructuring And Related Activities [Abstract]
Summary of Restructuring-Related Expense	The following table summarizes the above restructuring-related expenses by line item within the condensed consolidated statements of operations and comprehensive loss (in thousands): Nine Months Ended September 30, 2020 Cost of revenue $ 127 Sales and marketing 1,763 Research and development 1,681 General and administrative 801 Total $ 4,372

Organization And Description _2

Organization And Description of Business - Additional Information (Details) $ / shares in Units, $ in Thousands	May 24, 2021USD ($)$ / sharesshares	May 19, 2021USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)
Class Of Stock [Line Items]
Proceeds from initial public offering, net of underwriting commissions and discounts			$ 665,129
Stock issuance costs			$ 3,846	$ 2,280
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, shares | shares	85,331,278
IPO
Class Of Stock [Line Items]
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs, shares | shares	10,410,000
Share price | $ / shares	$ 67
Common stock pursuant to exercise in full of underwriters’ option to purchase additional shares | shares	940,000
Proceeds from initial public offering, net of underwriting commissions and discounts	$ 665,100
Underwriting discounts and commissions	32,300
Stock issuance costs	$ 7,500
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, shares | shares	85,331,278
Redeemable convertible preferred stock conversion ratio	1
IPO | Restricted Stock Units
Class Of Stock [Line Items]
Recognized stock-based compensation expense		$ 115,300

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)Segment	Sep. 30, 2020USD ($)	May 24, 2021USD ($)	Dec. 31, 2020USD ($)	Mar. 31, 2020USD ($)
Disclosure Of Summary Of Significant Accounting Policies [Line Items]
Number of operating segments | Segment			1
Deferred offering costs	$ 0		$ 0		$ 7,500,000	$ 5,000,000
Investments in equity securities						0
Impairment on investments			0
Deferred revenue, revenue recognized	111,400,000	$ 86,900,000	197,400,000	$ 161,500,000
Aggregate amount of transaction price allocated to remaining performance obligations	$ 497,300,000		$ 497,300,000
Percentage of remaining performance obligation expects to recognize as revenue	72.00%		72.00%
Series I Warrant
Disclosure Of Summary Of Significant Accounting Policies [Line Items]
Warrant liability							$ 11,900,000
Money Market Funds
Disclosure Of Summary Of Significant Accounting Policies [Line Items]
Cash equivalents	$ 1,051,900,000		$ 1,051,900,000			$ 363,100,000
Other Assets
Disclosure Of Summary Of Significant Accounting Policies [Line Items]
Investments in equity securities	$ 3,500,000		$ 3,500,000

Business Combination - Addition

Business Combination - Additional Information (Details) - USD ($) $ in Thousands	May 03, 2021	Sep. 30, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill		$ 137,375	$ 125,966
Indus.ai Inc.
Business Acquisition [Line Items]
Business acquisition, percentage of outstanding voting interests	100.00%
Preliminary purchase consideration in cash	$ 24,300
Purchase consideration held back for indemnification obligations accordance with stock purchase agreement	4,100
Deferred tax liability	2,000
Goodwill	11,500
Indus.ai Inc. | Developed Technology Intangible Assets
Business Acquisition [Line Items]
Purchase consideration allocated to intangible assets, estimated fair value	$ 14,800
Intangible asset, estimated useful life	5 years

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Finite-lived Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 55,888	$ 41,591
Accumulated Amortization	(14,699)	(8,350)
Net Carrying Amount	41,189	33,241
Developed Technology
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	39,438	25,141
Accumulated Amortization	(10,816)	(5,817)
Net Carrying Amount	28,622	19,324
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	16,450	16,450
Accumulated Amortization	(3,883)	(2,533)
Net Carrying Amount	$ 12,567	$ 13,917

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Residual value of intangible assets	$ 0
Goodwill impairment	$ 0	$ 0

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Summary of Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Finite Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	$ 2,397	$ 1,348	$ 6,377	$ 3,983
Cost of Revenue
Finite Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	1,086	761	3,258	2,283
Sales and Marketing
Finite Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	404	404	1,349	1,212
Research and Development
Finite Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	$ 907	$ 183	$ 1,770	$ 488

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Goodwill Roll Forward
Beginning balance	$ 125,966
Additions	11,464
Other adjustments, net	(55)
Ending balance	$ 137,375

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Components of Accrued Expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accrued Liabilities Current [Abstract]
Accrued commissions and bonuses	$ 21,064	$ 14,120
Accrued salary and payroll tax liabilities	13,031	5,818
Other accrued expenses	21,968	8,554
Total accrued expenses	$ 56,063	$ 28,492

Credit Facility - Additional In

Credit Facility - Additional Information (Details)	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity	$ 100,000,000	$ 100,000,000
Line of credit facility covenant liquidity ratio minimum	1.25
Credit facility amount drawn	$ 0	0
Letters of credit outstanding	6,400,000	7,000,000
Maximum
Line Of Credit Facility [Line Items]
Aggregate principal amount available under the credit facility	$ 75,000,000	$ 75,000,000

Redeemable Convertible Prefer_3

Redeemable Convertible Preferred Stock - Additional Information (Details) $ in Millions	May 24, 2021USD ($)shares	Dec. 31, 2020USD ($)shares	Mar. 31, 2020USD ($)shares
Redeemable Convertible Preferred Stock [Line Items]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, shares	85,331,278
Number of redeemable convertible preferred stock converted to common stock	85,331,278
Stock conversion, preferred stock conversion ratio	1
Conversion of stock, amount converted | $	$ 728.4
Series I Redeemable Convertible Preferred Stock Warrant
Redeemable Convertible Preferred Stock [Line Items]
Number of preferred shares the warrant can purchase			1,452,513
Fair value of warrants liability | $			$ 11.9
Issuance of redeemable convertible preferred stock		1,452,513
proceeds from issuance of convertible preferred stock | $		$ 55

Redeemable Convertible Prefer_4

Redeemable Convertible Preferred Stock - Summary of Inputs Used in Black-Scholes Option Pricing Model in Determining Fair Value of Warrant Liability (Details) - Series I Redeemable Convertible Preferred Stock Warrant	Sep. 30, 2020$ / shares	Jun. 30, 2020$ / shares	Mar. 31, 2020$ / shares
Fair Value of Preferred Stock Per Share
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair value of Series I redeemable convertible preferred stock per share	$ 49.95	$ 47.67	$ 35.04
Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Expected term (in years)	6 months	9 months	1 year
Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Measurement input	0.5910	0.6780	0.6690
Interest Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Measurement input	0.0010	0.0016	0.0016
Dividend Yield
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Measurement input	0	0	0

Redeemable Convertible Prefer_5

Redeemable Convertible Preferred Stock - Summary of Changes in Fair Value of Warrant Liability (Details) - Series I Redeemable Convertible Preferred Stock Warrant - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 22,528	$ 0
Issuance of Series I warrant		11,923
Change in fair value measurement of Series I warrant liability	(1,002)	9,603
Ending balance	$ 21,526	$ 21,526

Common Stock - Additional Infor

Common Stock - Additional Information (Details)	May 24, 2021vote$ / sharesshares	Sep. 30, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares
Class Of Stock [Line Items]
Common stock, shares authorized | shares		1,000,000,000	138,490,810
Common stock, par value | $ / shares		$ 0.0001	$ 0.0001
Preferred stock, shares authorized | shares		100,000,000	0
Preferred stock, par value | $ / shares		$ 0.0001
IPO
Class Of Stock [Line Items]
Common stock, shares authorized | shares	1,000,000,000
Common stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized | shares	100,000,000
Preferred stock, par value | $ / shares	$ 0.0001
Number of votes per share | vote	1

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details)	May 24, 2021	May 20, 2021USD ($)PurchasePeriodshares	May 19, 2021USD ($)	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2019$ / sharesshares	Sep. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)shares	Sep. 30, 2020USD ($)shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense							$ 38,183,000		$ 10,015,000	$ 185,929,000	$ 22,341,000
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total unrecognized stock-based compensation expense							185,300,000			$ 185,300,000
Expected to be amortized over a weighted-average vesting period (in years)										1 year 6 months
Number of shares, vested | shares										2,069,549
Restricted Series H-1 Redeemable Convertible Preferred Stock Awards (“RSAs”)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock-based compensation expense							200,000		$ 700,000	$ 1,600,000	$ 2,100,000
Number of shares granted | shares						205,464
Weighted average grant date fair value, granted | $ / shares						$ 26.75
Number of shares, vested | shares										205,464	102,732
Redeemable convertible preferred stock conversion ratio	1
Restricted Series H-1 Redeemable Convertible Preferred Stock Awards (“RSAs”) | First Anniversary
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares released from restriction					50.00%
Restricted Series H-1 Redeemable Convertible Preferred Stock Awards (“RSAs”) | Second Anniversary
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares released from restriction				50.00%
IPO
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Redeemable convertible preferred stock conversion ratio	1
IPO | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock-based compensation expense			$ 115,300,000
IPO | Restricted Stock Units | Quarterly or Annual Vesting Schedule
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
RSUs vesting period										4 years
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total unrecognized stock-based compensation expense							16,100,000			$ 16,100,000
Expected to be amortized over a weighted-average vesting period (in years)										7 months 6 days
Stock-based compensation expense							$ 4,600,000			$ 3,500,000
Offering period		12 months
Number of purchase periods | PurchasePeriod		2
Duration of purchase periods		6 months
Percentage of eligible compensation		15.00%
Maximum amount each participant can contribute to a defined contribution plan per calendar year		$ 25,000
Maximum number of shares each participant can purchase during purchase period | shares		2,500
Purchase price, threshold percentage of fair market value		85.00%
Expected dividend yield utilized							0.00%			0.00%
Employee payroll contributions accrued							$ 7,700,000			$ 7,700,000
Common stock, purchased | shares										0
Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense								$ 5,500,000
Sales of common stock at a price in excess of estimated fair value							$ 0
Common Stock | Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of shares of common stock that may be issued | shares		2,600,000
Percentage of outstanding shares		1.00%
Maximum number of additional shares of common stock that may be issued | shares		3,900,000
Number of period of common stock reserved for issuance		10 years
2021 Equity Incentive Plan | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares initially available for issuance | shares		30,962,615

Stock-based Compensation - Summ

Stock-based Compensation - Summary of Stock Option Activity (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award Additional General Disclosures [Abstract]
Number of shares outstanding	12,410,041
Number of shares exercised	(3,439,021)
Number of shares cancelled/forfeited	(599,573)
Number of shares outstanding	8,371,447
Number of shares exercisable	6,201,192
Weighted average exercise price, outstanding	$ 12.51
Weighted average exercise price, exercised	10.03
Weighted average exercise price, cancelled/forfeited	19.71
Weighted average exercise price, outstanding	13.02
Weighted average exercise price, exercisable	$ 10.81

Stock-based Compensation - Su_2

Stock-based Compensation - Summary of Activity in Connection with RSUs (Details) - Restricted Stock Units	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Number of Shares
Number of shares outstanding | shares	5,357,120
Number of shares granted | shares	3,016,957
Number of shares released | shares	(2,069,549)
Number of shares cancelled/forfeited | shares	(610,710)
Number of shares outstanding | shares	5,693,818
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, outstanding | $ / shares	$ 31.20
Weighted average grant date fair value, granted | $ / shares	69.49
Weighted average grant date fair value, released | $ / shares	31.15
Weighted average grant date fair value, cancelled/forfeited | $ / shares	42.26
Weighted average grant date fair value, outstanding | $ / shares	$ 50.32

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Estimate Fair Value of ESPP Purchase Rights on Date of Grant (Detail) - Employee Stock Purchase Plan	9 Months Ended
	Sep. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Estimated dividend yield	0.00%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate	0.03%
Expected term (in years)	6 months
Estimated weighted-average volatility	63.42%
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate	0.05%
Expected term (in years)	1 year 6 months
Estimated weighted-average volatility	69.39%

Stock-based Compensation - Su_3

Stock-based Compensation - Summary of Total Stock-based Compensation Cost from RSUs, Stock Options, RSAs, ESPP and Sales of Stock (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 38,183	$ 10,015	$ 185,929	$ 22,341
Stock-based compensation capitalized for software development	2,251	19	3,171	483
Total stock-based compensation cost	40,434	10,034	189,100	22,824
Cost of Revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	679	633	6,758	1,168
Sales and Marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	11,178	3,410	57,285	8,644
Research and Development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	15,064	2,898	69,627	6,747
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 11,262	$ 3,074	$ 52,259	$ 5,782

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 11	$ 224	$ 177	$ 468
Federal statutory income tax rate			21.00%

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Weighted Average Potentially Dilutive Shares are Excluded from Calculation of Diluted Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share	15,251,612	104,708,606	61,148,695	102,789,207
Shares of Common Stock Issuable Upon Conversion of Redeemable Convertible Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share		83,393,642	44,697,336	81,921,552
Shares of Common Stock Issuable Upon Conversion of Series I Warrant
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share		1,452,513		980,711
Restricted Stock Units Subject to Future Vesting
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share	5,834,027	4,578,156	6,057,965	3,454,658
Shares Issuable Pursuant to ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share	598,844		261,035
Shares of Common Stock Issuable from Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted-average potentially dilutive shares are excluded from calculation of diluted earnings per share	8,818,741	15,284,295	10,132,359	16,432,286

Geographic Information - Summar

Geographic Information - Summary of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Revenue	$ 131,990	$ 101,891	$ 368,718	$ 290,781
United States
Segment Reporting Information [Line Items]
Revenue	$ 111,774	$ 89,378	$ 315,711	$ 255,860
United States | Revenue Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of revenue by geographic region	85.00%	88.00%	86.00%	88.00%
Rest of the World
Segment Reporting Information [Line Items]
Revenue	$ 20,216	$ 12,513	$ 53,007	$ 34,921
Rest of the World | Revenue Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of revenue by geographic region	15.00%	12.00%	14.00%	12.00%

Restructuring - Additional Info

Restructuring - Additional Information (Details)	1 Months Ended	3 Months Ended	9 Months Ended
	Jul. 31, 2020Employee	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)
Restructuring Cost And Reserve [Line Items]
Restructuring and related activities, initiation date	Jul. 31, 2020
Restructuring and related activities, completion date	Dec. 31, 2020
Restructuring-related expenses | $		$ 4,400,000	$ 0	$ 4,400,000
Business Transformation Plan
Restructuring Cost And Reserve [Line Items]
Number of employees terminated | Employee	139
Percentage of workforce has been terminated	7.00%

Restructuring - Summary of Rest

Restructuring - Summary of Restructuring-Related Expense (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Restructuring Cost And Reserve [Line Items]
Total	$ 4,372
Cost of Revenue
Restructuring Cost And Reserve [Line Items]
Total	127
Sales and Marketing
Restructuring Cost And Reserve [Line Items]
Total	1,763
Research and Development
Restructuring Cost And Reserve [Line Items]
Total	1,681
General and Administrative
Restructuring Cost And Reserve [Line Items]
Total	$ 801

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	Nov. 02, 2021	Oct. 21, 2021	Nov. 05, 2021	Sep. 30, 2021
RSU
Subsequent Event [Line Items]
Weighted average grant date fair value, granted				$ 69.49
Subsequent Event | LaborChart and Levelset Acquisition | RSU
Subsequent Event [Line Items]
Common stock, shares			882,892
Estimated consideration			$ 81.4
Subsequent Event | LaborChart and Levelset Acquisition | RSU | Minimum [Member]
Subsequent Event [Line Items]
Weighted average grant date fair value, granted			$ 90.84
Subsequent Event | LaborChart and Levelset Acquisition | RSU | Maximum
Subsequent Event [Line Items]
Weighted average grant date fair value, granted			$ 100.10
Subsequent Event | LaborChart, Inc.
Subsequent Event [Line Items]
Estimated consideration		$ 85
Subsequent Event | Levelset
Subsequent Event [Line Items]
Common stock, shares	810,169
Estimated consideration	$ 500
Cash	425
Common stock	75
Fair value of common stock issued	77
Cash consideration held in escrow	$ 35